期刊文献+

肿瘤坏死因子促进内皮细胞微颗粒释放的实验研究 被引量:13

Tumor necrosis factor-α induces release of endothelial microparticles from human endothelial cells
原文传递
导出
摘要 目的研究肿瘤坏死因子损伤人脐静脉内皮细胞促进内皮细胞微颗粒释放,提出内皮细胞微颗粒是反映内皮损伤和功能障碍的新指标。方法应用肿瘤坏死因子-α刺激人脐静脉内皮细胞,扫描电镜观察细胞表面形态及内皮细胞微颗粒的生成,应用流式细胞仪检测细胞培养液中血小板细胞黏附分子(CD31+)和玻连蛋白(CD51+)微颗粒的水平。结果扫描电镜观察到静息状态下内皮细胞生成的微颗粒较少,经肿瘤坏死因子-α刺激24h后内皮细胞表面呈“出疹样”改变,小泡数目明显增多,直径大小约1.0μm。流式细胞仪检测证实细胞培养液中肿瘤坏死因子-α刺激组较正常对照组内皮细胞微颗粒水平明显增高[CD31+内皮细胞微颗粒,(164±63)/1000内皮细胞比(42±10)/1000内皮细胞,P<0.05;CD51+内皮细胞微颗粒,(260±108)/1000内皮细胞比(19±4)/1000内皮细胞,P<0.05]。结论肿瘤坏死因子损伤内皮细胞导致内皮细胞微颗粒释放增多,内皮细胞微颗粒有望成为评估内皮损伤替代指标之一。 Objective The present study was designed to investigate whether Tumor necrosis factor (TNF)-α stimulates release of endothelial microparticles( EMPs ) by human endothelial cells, and whether EMPs may serve as a promising marker for endothelial injury and dysfunction. Methods Human umbilical venous endothelial cells (HUVEC) were incubated with or without TNF-α for 24 hours at 37℃. EMPs generated on the surface of HUVEC were observed with a scanning electron microscopy. The CD31 and CD51 positive EMPs in culture supernatants were measured by flow cytometer. Results Fewer vesicles were observed on cell surface of control group, in TNF-et-stimulated one, however, cells manifested a blebby surface (eruption phenomenon ) and more vesicles on surface were observed. The levels of EMPs were significantly increased in TNF-et stimulated cells compared with controls [ CD31 + EMP, (164 ± 63 )/1000 cells vs. (42 ± 10)/1000 cells,P 〈0. 05;CD51 + EMP, (260 ± 108)/1000 cells vs. ( 19±4)/1000 cells, P 〈0. 05]. Conclusion TNF-α can stimulate HUVEC to release EMPs which may serve as a surrogate marker for endothelial injury and dysfunction.
出处 《中华心血管病杂志》 CAS CSCD 北大核心 2005年第12期1137-1140,共4页 Chinese Journal of Cardiology
基金 国家自然科学基金资助项目(30470475)
  • 相关文献

参考文献18

  • 1Lusis AJ.Atherosclerosis.Nature,2000,407:233-241.
  • 2Libby P.Current concepts of the pathogenesis of the acute coronary syndromes.Circulation,2001,104:365-372.
  • 3Combes V,Simon AC,Grau GE,et al.In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant.J Clin Invest,1999,104:93-102.
  • 4Jimenez J,Jy W,Mauro LM,et al.Elevated endothelial microparticles in thrombotic thrombocytopenic purpura:findings from brain and renal microvascular cell culture and patients with active disease.Br J Haematol,2001,112:81-90.
  • 5Brodsky SV,Malinowski K,Golightly M,et al.Plasminogen activator inhibitor-1 promotes formation of endothelial microparticles with procoagulant potential.Circulation,2002,106:2372-2378.
  • 6Sabatier F,Roux V,Anfosso F,et al.Interaction of endothelial microparticles with monocytic cells in vitro induces tissue factor-dependent procoagulant activity.Blood,2002,99:3962-3970.
  • 7Brogan PA,Dillon MJ.Endothelial microparticles and the diagnosis of the vasculitides.Intern Med,2004,43:1115-1119.
  • 8Sims PJ,Faioni EM,Wiedmer T,et al.Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity.J Biol Chem,1988,263:18205-18212.
  • 9Heijnen HF,Schiel AE,Fijnheer R,et al.Activated platelets release two types of membrane vesicles:microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules.Blood,1999,94:3791-3799.
  • 10Hamilton KK,Hattori R,Esmon CT,et al.Complement proteins C5b-9 induce vesiculation of the endothelial plasma membrane and expose catalytic surface for assembly of the prothrombinase enzyme complex.J Biol Chem,1990,265:3809-3814.

二级参考文献25

  • 1Anderson AD, Uehata A, Gerhard MD, et al. Close relationship of endothelial function in the human coronary and peripheral circulations. Am Coll Cardiol, 1995,26:1235-1241.
  • 2Cohn JN. Vascular wall function as a risk marker of cardiovascular disease. J Hypertens, 1999, 17:S41-S44.
  • 3Grey E, Bratteli C, Glasser SP, et al. Reduced small artery but not large artery elasticity is a independent risk marker for cardiovascular events. Am J Hypertens, 2003,16:265-269.
  • 4De Meyer GR, Herman AG. Vascular endothelium dysfunction. Prog Cardiovasc Dis, 1997,39:325-334.
  • 5Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet, 1992,340:1111-1115.
  • 6Jin ZG, Ueba H, Tanimoto T, et al. Ligand-Independent activation of vascular endothelial growth factor receptor 2 by fluid shear stress regulates activation of endothelial nitric oxide synthase. Circ Res, 2003,93:354-363.
  • 7Cohn JN. Vascular compliance and cardiovascular implications. Heart Dis, 2002,2:52-56.
  • 8Tao J, Jin YF, Yang Z, et al. Reduced arterial elasticity is associated with endothelial dysfunction in persons of advancing age: comparative study of non-invasive pulse wave analysis and laser dopper blood flow measurement. Am J Hypertens, 2004,17:654-659.
  • 9Oliver JJ, Webb DJ. Noninvasive assessment of arterial stiffness and risk of atherosclerotic events. Arterioscler Thromb Vascular Biol, 2003, 23:168-175.
  • 10Wilkinson IB, Qasem A, McEniery CM, et al. Nitric oxide regulates local arterial distensibility in vivo. Circulation, 2002, 105:213-217.

共引文献58

同被引文献151

  • 1陶军,王妍,杨震,涂昌,徐明国,王洁梅,王强,曾群英,陈国伟,马虹.年龄相关的循环内皮祖细胞变化与动脉弹性关系的研究[J].中华心血管病杂志,2005,33(4):347-350. 被引量:20
  • 2王妍,陶军,涂昌,陈龙,杨震,徐明国,王洁梅,黄奕俊.高血压患者循环内皮细胞微颗粒水平的变化[J].中华老年心脑血管病杂志,2006,8(4):222-224. 被引量:15
  • 3[1]Jimenez JJ,Jy W,Mauro LM,et al.Endothelial microparticles released in thrombotic thrombocytopenic purpura express von Willebrand factor and markers of endothelial activation[J].Br J Haematol,2003,123:896-902.
  • 4[2]Colernan ML,Sahai EA,Yeo M,et al.Membrane blebbing dunig apoptosis results from caspase mediated activation of Rock Ⅰ[J].Nat Cell Biol,2001,3:339-345.
  • 5[3]Combes V,Simon A-C,Grau G-E,et al.In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant[J].J Clin Invest,1999,104:93-102.
  • 6[4]Sabatier F,Roux V,Anfosso F,et al.Interaction of endothelial microparticles with monocytic cells in vitro induces tissue factordependent procoagulant activity[J].Blood,2002,99:3962-3970.
  • 7[5]Jy W,Minagar A,Jimenez JJ,et al.Endothelial microparticles(EMP) bind and activate monocytes:elevated EMP-monocyte conjugates in multiple sclerosis[J].Front Biosci,2004,9:3137-3144.
  • 8[6]Jimenez J,Jy W,Mauro LM,et al.Elevated endothelial microparticle-monocyte complexes induced by multiple sclerosis plasma and the inhibitory effects of interferon-beta 1b on release of endothelial microparticles,formation and transendothelial migration of monocyte-endothelial microparticle complexes[J].Mult Scler,2005,11:310-315.
  • 9[7]Brodsky SV,Malinowski K,Golightly M,et al.Plasminogen activator inhibitor-1 promotes formation of endothelial microparticles with procoagulant potential[J].Circulation,2002,106:2372-2378.
  • 10[8]Heloire F,Weill B,Weber S,et al.Aggregates of endothelial microparticles and platelets circulate in peripheral blood.Variations during stable coronary disease and acute myocardial infarction[J].Thromb Res,2003,110:173-180.

引证文献13

二级引证文献84

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部